Ito, K., Mitsunaga, M., Arihiro, S., Saruta, M., Matsuoka, M., Kobayashi, H., & Tajiri, H. (2016). Molecular targeted photoimmunotherapy for HER2-positive human gastric cancer in combination with chemotherapy results in improved treatment outcomes through different cytotoxic mechanisms. BMC Cancer.
Chicago-стиль цитированияIto, Kimihiro, Makoto Mitsunaga, Seiji Arihiro, Masayuki Saruta, Mika Matsuoka, Hisataka Kobayashi, and Hisao Tajiri. "Molecular Targeted Photoimmunotherapy for HER2-positive Human Gastric Cancer in Combination With Chemotherapy Results in Improved Treatment Outcomes Through Different Cytotoxic Mechanisms." BMC Cancer 2016.
MLA-цитированиеIto, Kimihiro, et al. "Molecular Targeted Photoimmunotherapy for HER2-positive Human Gastric Cancer in Combination With Chemotherapy Results in Improved Treatment Outcomes Through Different Cytotoxic Mechanisms." BMC Cancer 2016.